Traditional radiation planning methods

Traditional radiation planning methods involve choosing the number, direction and arrangement of radiation beams and determining the resultant dose distribution. The plan chosen is the one that provides the best dose coverage to the target while minimizing dose to the surrounding normal tissues is chosen and this is known as forward planning. Intensity modulated radiation therapy is currently the most advanced approach for delivering highly conformal radiation therapy. This technique can achieve even more tightly conformal dose distributions through the use of nonuniform intensity radiation beams. Each beam is divided into multiple segments or beamlets Each beamlet can have different intensity thereby modulating the intensity of each beam. In contrast to the traditional method of radiation planning, IMRT works backward by choosing the desired dose distribution first and then determining the required number of beams and intensities needed to achieve this dose distribution.

This is known as inverse planning. The target volume and critical normal organs are defined and the upper and lower dose limits for the target and normal structures selected. The quality of the plan is assessed using DVHs (Figure 5). At most high volume institutions, IMRT has become the new standard of care for the treatment of men with prostate cancer using EBRT. Intensity modulated radiation therapy is a powerful technique for escalating dose and reducing toxicity. Central to achieving this goal is the recognition and adoption of strict normal tissue constraints.
Rectal side effects are manifest within 2-4 years,18 while bladder and erectile tissue side effects mature over a much longer time course.

Objective DVH criteria have clearly been associated with rectal toxicity.19, 20 The prostate (± seminal vesicles) represents the CTV. The prostate, particularly at the bladder/prostate base superiorly and the prostate apex/urogenital diaphragm inferiorly is better defined on MRI than CT (Figure 6). Also, the boundaries of the sur- rounding normal structures (bladder, rectum, penile bulb) are more easily defined on MRI. In fact, several studies have suggested that CT overestimates the prostate volume by 30-40% over MRI. Conditions for plan acceptance should include that 95-100% of the PTV receives the prescription dose. The CTV should receive 100% of the prescription dose.

The maximum dose to the PTV should not exceed the prescribed dose by more than 17% and <1% of the PTV should receive less than 65 Gy (usually <0.5%). The FCCC PTV margins are 8 mm in all dimensions, except posteriorly at the prostaterectal interface, where a 5 mm margin is planned. These margins are acceptable only when daily localization is performed. The FCCC normal tissue constraints are derived in part from the M.D. Anderson Cancer Center (MDACC) randomized trial. In that study there was a dramatic increase in ≥grade 2 rectal reactions when ≥25% of the rectal volume received ≥70 Gy. The constraints for the rectum are ≤17% and ≤35% of the rectum receives ≥65 Gy and ≥40 Gy, re- spectively. Constraints to the bladder and erectile tissues are less well-defined. However, recent data from FCCC has demonstrated the ability to limit the dose to the erectile bodies without sacrificing prostate dose homo- geneity criteria (maximum prostate dose <120% prescribed dose) and rectal tolerance criteria.
Treatment results Individual institutions defined bNED control following RT differently prior to the development of the ASTRO definition of PSA control. Comparison of treatment results was difficult if not impossible. Statistically significant differences in bNED control could be seen by merely changing the definition of bNED control when keeping all other variables stable. A conference of prostate cancer experts was held at the request of the American Society of Therapeutic Radiology and Oncology (ASTRO) in 1996 and a unified definition of bNED control was developed for reporting successes or failures following irradiation.

The definition selected by this group was designed for clinical practice as well as research trials and did not require a specific single value for post-treatment nadir PSA to determine success or failure. The ASTRO definition defined failure as 3 consecutive rises in post-treatment PSA after achieving a nadir. The date of failure (DOF) was backdated to the time midway between the post-treatment PSA nadir and the first of the consecutive rises in PSA.

Filed under Health News | Comment (0)

Physical examination, serum PSA

This may be particularly important in evaluating the borders of the prostate at the apex and base (Fig. 3). Some authors have advocated the combination of imaging modalities for postimplant dosimetry. The timing of postimplant dosimetry remains controversial. Edema develops in the prostate following seed placement, and it is thought that this affects immediate postimplant dosimetry. Waterman et al reported a 10% underestimate of calculated prostate coverage when CT was performed immediately following the implant procedure. The optimal time for postimplant dosimetry also may differ by isotope. Yue et al performed an image-based dose evaluation for I-125 and Pd-103 prostate brachytherapy implants. Based on the model used, they recommended that postimplant dosimetry be performed at 7 weeks postimplant for I-125 and at 3 weeks postimplant for Pd-103. Because there still remains a lack of consensus with regard to the ideal time for postimplant dosimetry, the ABS recommends that each center perform dosimetric evaluation at a consistent interval. Physical examination, serum PSA, and prostate biopsy The intervals in which patients are seen in the clinic following brachytherapy are dependent on several factors that pertain to the biology of the tumor, treatment algorithm, and side-effect profile experienced by the patient. Patients are seen initially 2 to 3 weeks after brachytherapy for postimplant dosimetry as described above. The next office visit is at 6 to 8 weeks, at which point an evaluation of the patients voiding function is performed. This consists of the application of a voiding questionnaire to quantify a symptom score, combined with evaluation of the postvoid residual, preferably by ultrasonography. The Fig. 1. Multiple CT slices of prostate with postimplant isodose lines overlaid (blue, 100% of dose; aqua, 150% of dose; yellow, 75% of dose). Fig. 2. Comparison between MRI and CT images of the same patient at the same level for radiation planning. Fig. 3. Comparison between postimplant MRI and CT images of the same patient at the same level. E.M. Horwitz et al / Urol Clin N Am 30 (2003) 737–750 741 latter examination is particularly important because a significant minority of patients develop acute urinary retention. Therefore, in patients who are not managed with alpha-receptor antagonists in the pre and postoperative period, initiation of such agents is advisable in the presence of significant postvoid residual. In addition, patients who develop sexual dysfunction [13–15]—due to androgen deprivation or secondary to the brachytherapy procedure are offered management options at this time. Patients with low-risk disease usually are followed every 6 months with a digital rectal examination and PSA. This examination protocol is continued for the first 5 years, after which the frequency is reduced to yearly visits. A similar protocol can be used for patients with high-risk disease, although in many cases such patients have examinations and PSA analysis performed every 3 to 4 months in the first 3 years, followed by a reduction to every 6 months for the next 2 or 3 years, with yearly follow-up thereafter. Recently, nomograms have been developed for patients treated with brachytherapy that can help to guide the intensity of follow-up based on the risk of recurrence. The added benefit of routine prostate biopsies in following brachytherapy in the absence of biochemical failure is unclear. In the setting of EBRT, Crook et al reported prospectively on 226 patients and showed that for those patients with PSA levels near nadir after radiation, there is little value in performing biopsy. Most recently, the American Society for Therapeutic Radiology and Oncology (ASTRO) reported a consensus panel recommendation that routine prostate biopsy should not be performed for evaluation of PSA recurrence after EBRT unless salvage prostatectomy or other salvage procedures were being considered. In addition, if a new nodule is palpated at the follow-up examination, a biopsy should be performed only if the patient is a candidate for potentially curative approaches (discussed below).

Filed under Health Online | Comment (0)

New Guinea Papua Has Highest HIV/FACILITY, Factor IIT In Region Asia-Pacific

The New Guinea Papua has an most upper spreading HIV/FACILITIES and sexual sent infections in region Asia-Pacific, according to medical researcher and expert, speaking in 40-y anniversary and colloquium Institute PNG Medical Study, PACNews/messages of the Deal (the business) Island. During HIV/presentations of the FACILITIES, the physician John Millan has said that to December 2007, more, than 23,000 events are reported in country, including 5,000 new are diagnosed. More, than 76,000 positive people HIV-alive in country. Ninety-four percents HIV/events of the FACILITIES in New Guinea Papua were sent through heterosexual methods and 4% were sent through the other methods, he has added.

Millan has Said that according to raw datas got from Mingende and hospitals Kundiawa in provinces Simbu, events HIV were more high amongst young girl and more old mans. SPREADING HIV increases quicker in rural area than in town area, Millan was added.

In separate presentation on sexual health, the Law of the physician Greg “mentionned, which IIT and HIV wide-spread where right of the women least valuable and dear,” according to PACNews/Deal (the business) Island. The Law said that sexual health must be advanced in New Guinea Papua, together with corresponding to sexual hygiene and access to required water supply. He has added that negation and defect to abilities to discuss sexual health, questions assist increase in IIT and HIV/events of the FACILITIES.

Filed under Health Online | Comment (0)

The Senate Labor-HHS Ticket Advances In Senate; House Ticket Stops

The Committee of the Conferring the Senate in Thursday approved $153.1 spending count that must finance the Labour, HHS and divisions of the Formation for fiscal year 2009, Today messages CQ. The Participants of the Committee voted 26-3 to approve the count Wayne, CQ Today.

The Count includes 25% reduction on funding for basing public temperance-only forming the programs before $84.8 millions for FY 2009. Legislation also must provide $300 million for family planning the programs of the Name X, same financing level as in FY 2008. The Measure also must enlarge funding for public centre of the health $150 million before $2.2 Besides, measure provides the level financing for breast and cervical cancerous screening for low incom of the womans (the Policy of Health of the Daily Message of the Women(woman), 6/25).

The Committee of the apropriation speech voice adjustment was taken in Thursday, which must deny the federal directive to indicate the directors of health, which effectively forbid conditions to enroll the from family, earning more, than 250% federal level to poverty in Insurance Program of Health of the Condition Detey. The State Office to Account abilities have said that directive was illegal, Today messages CQ.

In the interim, version of the Building of the measure stopped In thursday as Republican checked to force the Committee of the Conferring the Building to vote in adjustment, which must increase the internal oil production. The Turnips. Jerry Lewis (R-CA), Committee senior Republican, offered adjustment, which must change the text Labor-HHS and count of the Formation with hereunder Internal Division, financing count. The Democrats of the Building voted to postpone rather then vote in adjustment. Devid Pulpits of the Committee will Comply with (D-Wis.) said Republican tried to break the process of the apropriation on political reason, addition of the displacement was “filibuster adjustment.”

Standpoint, Commentary
According to CQ Today, outlook for measure, the following for discrepancy in House vague. The Senate Majority Whip Richard Durbin (D-Ill.) said that he does not expect that Senate in measure by this summer. Besides, Bush may need to veto the measure since he includes $7.7 more in discretionary consuption than he has asked. Bush has said he will veto any consuption of the count, which exceeds his requests of the budget

Filed under Pharmacy News | Comment (0)